Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

354 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Unmet need in pulmonary hypertension-associated interstitial lung disease (PH-ILD): a clinician survey of real-world management of PH-ILD in Europe.
Montani D, Cifrián JM, Rojo RP, Nunes H, Meloni F, Ghio S, Cannon J, Günther A, Gálvez García H, Delgado MF, Jeanneret GSB, Howard L. Montani D, et al. Among authors: ghio s. ERJ Open Res. 2024 Jul 8;10(4):00039-2024. doi: 10.1183/23120541.00039-2024. eCollection 2024 Jul. ERJ Open Res. 2024. PMID: 38978553 Free PMC article.
Genetic counselling and testing in pulmonary arterial hypertension: a consensus statement on behalf of the International Consortium for Genetic Studies in PAH.
Eichstaedt CA, Belge C, Chung WK, Gräf S, Grünig E, Montani D, Quarck R, Tenorio-Castano JA, Soubrier F, Trembath RC, Morrell NW; for PAH-ICON associated with the PVRI. Eichstaedt CA, et al. Eur Respir J. 2023 Feb 23;61(2):2201471. doi: 10.1183/13993003.01471-2022. Print 2023 Feb. Eur Respir J. 2023. PMID: 36302552 Free PMC article.
Association of Phosphodiesterase-5 Inhibitor Treatment With Improved Survival in Pulmonary Hypertension Associated With COPD in the Pulmonary Vascular Research Institute GoDeep Meta-Registry.
Tello K, Yogeswaran A, Majeed RW, Kiely DG, Lawrie A, Brittain E, Annis JS, Olschewski H, Kovacs G, Hassoun PM, Balasubramanian A, Konswa Z, Sweatt AJ, Zamanian RT, Wilkins MR, Howard L, Arvanitaki A, Giannakoulas G, Cajigas HR, Frantz R, Williams PG, Frauendorf M, Marquardt K, Antoine T, Fuenderich M, Richter M, Grimminger F, Ghofrani HA, Wilhelm J, Seeger W; Pulmonary Vascular Research Institute GoDeep Consortium. Tello K, et al. Chest. 2025 Jan;167(1):224-240. doi: 10.1016/j.chest.2024.08.016. Epub 2024 Sep 7. Chest. 2025. PMID: 39182575
De Novo Truncating Mutations in WASF1 Cause Intellectual Disability with Seizures.
Ito Y, Carss KJ, Duarte ST, Hartley T, Keren B, Kurian MA, Marey I, Charles P, Mendonça C, Nava C, Pfundt R, Sanchis-Juan A, van Bokhoven H, van Essen A, van Ravenswaaij-Arts C; NIHR BioResource; Care4Rare Canada Consortium; Boycott KM, Kernohan KD, Dyack S, Raymond FL. Ito Y, et al. Am J Hum Genet. 2018 Jul 5;103(1):144-153. doi: 10.1016/j.ajhg.2018.06.001. Epub 2018 Jun 28. Am J Hum Genet. 2018. PMID: 29961568 Free PMC article.
Effects of sacubitril/valsartan on renal function and outcome in patients with heart failure and reduced ejection fraction: an Italian cohort study.
Palazzuoli A, Pirrotta F, Cartocci A, Delcuratolo E, Dini FL, Correale M, Dattilo G, Masarone D, Scelsi L, Ghio S, Tocchetti CG, Mercurio V, Brunetti ND, Nodari S, Barillà F, Ambrosio G, Carluccio E. Palazzuoli A, et al. Among authors: ghio s. Ther Adv Cardiovasc Dis. 2024 Jan-Dec;18:17539447241285136. doi: 10.1177/17539447241285136. Ther Adv Cardiovasc Dis. 2024. PMID: 39611607 Free PMC article.
Dapagliflozin Effects on Left Ventricular Remodeling and Filling Pressures in Heart Failure With Reduced Ejection Fraction.
Acquaro M, Scelsi L, Mascolo C, Pelosi C, Greco A, Turco A, Schirinzi S, Lattanzio M, Resasco T, Mercurio V, Di Lorenzo C, Marovino E, De Luca L, Ghio S. Acquaro M, et al. Among authors: ghio s. J Am Soc Echocardiogr. 2024 Oct 28:S0894-7317(24)00527-3. doi: 10.1016/j.echo.2024.10.009. Online ahead of print. J Am Soc Echocardiogr. 2024. PMID: 39490456
Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensus.
Manzi G, Benza RL, Argiento P, Casu G, Corda M, Correale M, D'Alto M, Galgano G, Garascia A, Ghio S, Gomberg-Maitland M, Mulé M, Paciocco G, Papa S, Prati D, Preston IR, Raineri C, Romeo E, Scelsi L, Stolfo D, Vitulo P, White RJ, Badagliacca R, Vizza CD. Manzi G, et al. Among authors: ghio s. Vascul Pharmacol. 2024 Dec;157:107432. doi: 10.1016/j.vph.2024.107432. Epub 2024 Sep 10. Vascul Pharmacol. 2024. PMID: 39265796 Review.
354 results